PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11887177-4	2002	ApoAI mRNA levels, assessed by Northern blotting, were suppressed in HepG2 cells treated with DHEA (34%) (10 microg/mL) or testosterone (36%) (T, 1 microg/mL).	Dehydroepiandrosterone	94-98	apolipoprotein A1	Homo sapiens	0-5	
11994339-9	2002	Compared with levels after placebo administration, high density lipoprotein cholesterol and apolipoprotein A-1 levels decreased after DHEA.	Dehydroepiandrosterone	134-138	apolipoprotein A1	Homo sapiens	92-110	
11887177-5	2002	Estradiol alone (E2, 1 microg/mL) had relatively little effect on apoAI mRNA levels, while E2 in combination with DHEA prevented a decrease in apoAI mRNA levels compared to DHEA alone.	Dehydroepiandrosterone	114-118	apolipoprotein A1	Homo sapiens	143-148	
11887177-11	2002	When the androgens (ie, DHEA, T, DHT, or MTT) were combined with E2, apoAI promoter activity was suppressed.	Dehydroepiandrosterone	24-28	apolipoprotein A1	Homo sapiens	69-74	
9660430-13	1998	Supplementation with DHEA increased IGF-I/IGFBP-3 levels at 3 months and decreased high-density lipoprotein and apolipoprotein A1 levels at 6 months.	Dehydroepiandrosterone	21-25	apolipoprotein A1	Homo sapiens	112-129